Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Net Income: 2020-2025

Historic Net Income for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$2.3 million.

  • Journey Medical's Net Income rose 3.14% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year increase of 53.41%. This contributed to the annual value of -$14.7 million for FY2024, which is 280.79% down from last year.
  • As of Q3 2025, Journey Medical's Net Income stood at -$2.3 million, which was up 38.04% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Net Income ranged from a high of $16.8 million in Q3 2023 and a low of -$21.8 million during Q4 2021.
  • Its 3-year average for Net Income is -$2.6 million, with a median of -$3.4 million in 2024.
  • In the last 5 years, Journey Medical's Net Income slumped by 36,810.34% in 2021 and then soared by 266.56% in 2023.
  • Over the past 5 years, Journey Medical's Net Income (Quarterly) stood at -$21.8 million in 2021, then soared by 51.07% to -$10.6 million in 2022, then soared by 79.86% to -$2.1 million in 2023, then surged by 173.82% to $1.6 million in 2024, then grew by 3.14% to -$2.3 million in 2025.
  • Its Net Income stands at -$2.3 million for Q3 2025, versus -$3.7 million for Q2 2025 and -$4.1 million for Q1 2025.